cambridge's bluebird bio licenses delivery tech to novartis, gsk..may 17, 2018.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..

.

editor's six of the best

.

"we were quite surprised to find there were no significant differences," says study author